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Abstract
Background
Patients’ illness beliefs have been associated with glycaemic control in diabetes and sur-
vival in other conditions.
Objective
We examined whether illness beliefs independently predicted survival in patients with dia-
betes and foot ulceration.
Methods
Patients (n = 169) were recruited between 2002 and 2007. Data on illness beliefs were col-
lected at baseline. Data on survival were extracted on 1st November 2011. Number of days
survived reflected the number of days from date of recruitment to 1st November 2011.
Results
Cox regressions examined the predictors of time to death and identified ischemia and iden-
tity beliefs (beliefs regarding symptoms associated with foot ulceration) as significant pre-
dictors of time to death.
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Conclusions
Our data indicate that illness beliefs have a significant independent effect on survival in
patients with diabetes and foot ulceration. These findings suggest that illness beliefs could
improve our understanding of mortality risk in this patient group and could also be the basis
for future therapeutic interventions to improve survival.
Introduction
The psychological functioning of patients with diabetes has been shown to be of clinical impor-
tance. For example, indices of psychological functioning have been associated with poorer met-
abolic control[1]; greater treatment non-adherence[2] and an increased risk of diabetic
complications.[3] Research with patients with diabetic foot ulcers (a lesion in the skin which
penetrates the dermis and occurs below the ankle) has also been suggestive of a role for psycho-
logical factors in predicting clinical outcomes. For example, in patients with, or at risk, from
foot ulceration, depression has been associated with an increased risk of ulceration,[4] delays
in the rate of ulcer healing[5] and a 2 fold greater risk of mortality.[6]
The evidence regarding the relationship between psychological functioning and outcomes
in patients with foot ulcers is, however, limited in two main ways. First, it has largely focussed
on depression and second, the evidence pertaining to the role of depression is equivocal. For
example, contrary to the studies cited above, data exist which suggest that depression is not
related to ulcer recurrence[4,6] or amputation.[7] Similarly, the effect of depression on ulcer
healing has been shown not to withstand adjustment for clinical predictors.[8] These observa-
tions lead us to speculate that a focus on depression alone may be limiting our understanding
of the ways in which psychological functioning can influence clinical outcomes in diabetic foot
ulceration; and that it may be necessary to examine the role of other psychological processes.
[5,9]
If we are to extend our assessment of psychological factors beyond depression, which factors
are worthy of further enquiry? The influential self-regulatory model of illness[10] can inform
this question. The model asserts that patients form illness beliefs when contending with a
health threat and that these beliefs play a central role in determining patients’ emotional and
behavioural responses to their illness. According to the current taxonomy patients’ beliefs cen-
tre around the following core constructs: identity (beliefs regarding the experience of symp-
toms associated with the illness); consequences (beliefs regarding the outcomes of the illness);
timeline (beliefs regarding the likely duration of the illness); personal control (beliefs regarding
one’s ability to influence the course of the illness); treatment control (beliefs regarding the
effectiveness of treatment to cure or control the illness); coherence (beliefs regarding one’s
understanding of the illness); emotional representations (beliefs regarding the emotional
impact of the illness) and causal representations (beliefs regarding the cause of the illness).
These beliefs are not held in isolation, but are hypothesised to interact with each other to form
an overall illness schema. The relationship between beliefs and outcomes is necessarily influ-
enced by the nature of the disease in question; and as such, specific beliefs or belief schema, are
not universally associated with positive or adverse outcomes.
Thus, while emotional responses, such as depression, arise in direct response to illness and
the threat of illness, illness beliefs are also influential in determining these emotional responses
and could, therefore, be expected to influence outcomes in patients with diabetic foot ulcers.
Evidence in support of this comes from the wider literature on patients with diabetes. For
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example, a recent systematic review provides evidence in support of illness beliefs being associ-
ated with glycaemic control in diabetes.[11] Furthermore, a study comparing the effects of
depression versus illness beliefs in predicting dietary, quality of life and glycaemic control out-
comes in diabetes, showed that illness beliefs were more consistent and stronger determinants
of these outcomes than depression.[12] Evidence pertaining specifically to patients with dia-
betic foot ulcers has shown that illness beliefs are important determinants of self-care, in partic-
ular foot-care practices: with patients identity, personal control and coherence beliefs found to
predict engagement with foot self-care.[13]
Of further relevance here is recent work with other patient groups which has shown that ill-
ness beliefs predict mortality. For example, van Dijk and colleagues[14] reported in a cohort of
patients with end stage renal disease that beliefs regarding treatment control predicted mortal-
ity: with death being more likely in patients who believed their treatment to be less effective.
Similar findings were reported by Chilcot, Wellstead and Farrington (2011) who also found
negative beliefs about the effectiveness of treatment predicted mortality in patients with end
stage renal disease.[15] More recently, Crawshaw, Rimington, Weinman and Chilcot (2015)
reported that changes in illness perceptions, specifically a change from positive to negative
beliefs, predicted mortality in patients who had undergone cardiac valve replacement.[16]
In sum, the evidence regarding the role of depression in predicting clinical outcomes in
patients with diabetic foot ulcers has been equivocal. In contrast, the emerging evidence on ill-
ness beliefs from patients with diabetes and other chronic conditions suggests they may be
influential in predicting a range of clinical outcomes, including mortality. We sought to add to
this literature by considering the role of depression and illness beliefs in predicting mortality in
patients with type 1 and type 2 diabetes and with a diabetic foot ulcer. In line with previous
research we hypothesised that the time to death would be shorter in patients with negative
beliefs[16]; and we specifically expected to find that beliefs regarding symptoms, personal con-
trol and/or coherence would be related to mortality in view of their role in predicting foot self-
care in this patient group.[13] Although, in view of the, as yet, limited evidence in this area, we
did not hypothesise as to the direction of these effects. Furthermore, in view of the prominence
of depression as a predictor of mortality in diabetes [6,7,17] our predictive models were con-
structed to examine whether illness beliefs predicted mortality after examining the role of
potential demographic and clinical determinants and depression.
Research Design and Methods
Procedure
Patients participated in a prospective observational study. At baseline, the following clinical
and demographic data were collected on all participants: age, gender, glycated haemoglobin
(HbA1c), number of previous ulcers, presence/absence of infection in ulcer, diabetes type, neu-
ropathy and ischemia and ulcer size. Participants also completed self-report measures of illness
beliefs,[18] and depression[19] at baseline. Data on survival were collected after the survival
census point (1st November 2011).
Patients
A convenience sample of patients with type 1 or type 2 diabetes mellitus and a foot ulcer was
recruited from outpatient podiatry clinics in secondary care in the UK between January 2002
and January 2007. Patients were recruited into a longitudinal research programme examining
psychological and behavioural aspects of diabetic foot ulceration. This study was approved by
the North Somerset & South Bristol Research Ethics Committee and all participating patients
provided written informed consent.
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All clinics subscribed to a standard regimen of foot care, i.e., aggressive debridement at each
visit, treatment of infections with antibiotics and the use of removable Scotch-casts and other
footwear/devices for offloading ulcers on weight-bearing areas, minimising the likelihood of
between-centre variations in treatment outcomes. Inclusion/exclusion criteria ensured the pop-
ulation consisted of patients with neuropathic or neuroischaemic ulcers. Patients were not eli-
gible if they had: no palpable pulses on the affected foot; a history of major amputation (i.e.,
any lower limb amputation greater than a single digit); known large vessel peripheral vascular
disease (e.g., previous bypass surgery, angioplasty); advanced diabetic retinopathy with severe
visual impairment; advanced nephropathy (e.g., on dialysis); other severe disabling medical
conditions (e.g., stroke); or were being treated with platelet-derived growth factor, tissue engi-
neered skin or total contact casts.
One hundred and sixty-nine patients were recruited. In November 2011, survival data (i.e.,
deceased versus alive at 1/11/11; and, if deceased, date of death) were requested from General
Practitioners. Data were available for 160 patients.
Measures
Illness beliefs. Participants completed the Brief Illness Perceptions Questionnaire (BIPQ)
[18] derived from the self-regulatory model of illness.[10] This instrument is recommended in
studies involving older participants and/or ill participants and so was selected for the present
study. The instrument captured patients’ beliefs regarding their foot ulcer in the following
domains: identity (‘How much do you experience symptoms?’); consequences (‘How much
does your ulcer affect your life?’); timeline (How long do you think your ulcer will continue?);
personal control (‘Howmuch control do you feel you have over your ulcer?’); treatment control
(‘How much do you think your treatment can help your ulcer?’); coherence (‘How well do you
feel you understand your ulcer?’) and emotional response (‘How much does your ulcer affect
you emotionally?’). The cause and concern items from this scale were excluded. The causal
item involves a response format that differs from the other belief items. Specifically, patients
respond to an open ended question with free text to indicate up to 3 causes of their condition.
As such no score is obtained and thus it cannot be analysed in the same way. It is, therefore,
common for researchers not to consider causal beliefs in quantitative analyses. Indeed, this is
the case for all of the previous studies which have looked at the role of illness beliefs in predict-
ing mortality.[14–16] With regard to the concern item, this is one of two items in the BIPQ
which capture emotional representations. In view of the age and frailty of our participants, we
included just one of the items exploring emotional representations as this allowed us to exam-
ine this aspect of the model whilst limiting participant burden. The range of scores for each
subscale was 0–10, with higher scores indicating a stronger belief in the relevant domain. The
reliability, concurrent and predictive validity of the instrument has been reported elsewhere.
[18,20]
Depression. Depression was measured using the depression subscale of the Hospital Anxi-
ety and Depression Scale (HADS).[19] The range of scores for this subscale was 0–21, with
higher scores reflecting higher levels of depression. The Cronbach’s alpha reliability coefficient
for the subscale in the present study was 0.849.
Glucose control. HbA1c was measured at baseline. This provides a surrogate marker of
disease control by providing an average of blood glucose levels in the previous 8–12 weeks.
HbA1c was measured by cation exchange high performance liquid chromatography using a
Menarini HA-8140 analyser and associated reagents (A. Menarini Diagnostics, Wokingham,
UK). The assay was maintained in alignment with the Diabetes Control and Complications
Trial method,[21] with no significant assay drift and a between-batch imprecision (CV) of
Illness Beliefs and Mortality
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1.8% (at mean HbA1c 5.5% [37 mmol/mol]). All assays were performed on the same
instrument.
Neuropathy and ischaemia assessments. Neuropathy was assessed by applying a 10g
nylon monofilament to a number of sites on the affected foot and patients reporting the pres-
ence/absence of sensation. Level of neuropathy was based upon the number of tested sites with
sensory loss. Percentage rather than absolute values were used as the number of sites assessed
varied between podiatrists. Ischaemia was assessed by measuring number of palpable pulses at
the dorsalis pedis and posterior tibial areas of the affected foot. All assessments were conducted
by the treating podiatrist at each centre.
Ulcer assessments. Data were collected from clinical records on all patients regarding the
number of previous ulcers, the size of the presenting ulcer and the presence/absence of infec-
tion in the presenting ulcer. The assessment of ulcer size involved placing a disposable trans-
parent film over the ulcer and tracing the topical area of the ulcer. The tracing was then placed
on a digital tablet (Visitrack: Smith and Nephew, London, UK) and the area of the ulcer was
re-traced with a stylus to produce a measurement of absolute ulcer area (in mm2). These assess-
ments were conducted by the treating podiatrist at each centre.
Statistical methods
Pearson’s correlations were computed to examine the inter-relationships between the individ-
ual illness belief domains. One way analysis of variance and chi-square analysis were conducted
to compare patients with and without missing survival data on all predictor variables. After
checking that assumptions were satisfied, survival analysis was undertaken using Cox regres-
sion models to examine the predictors of time to death. The survival outcome was number of
days survived from the date of recruitment to the census point (1/11/11) or death from any
cause. The survival analysis involved two stages. In the first, all potential clinical and demo-
graphic predictors and depression were examined in univariate analyses to identify significant
predictors. In the second step, all seven belief measures were added to only those covariates
identified as significant in the first step. This is in keeping with the self-regulatory model[10]
which argues that a patient’s understanding of their illness, and subsequent behavioural and
emotional responses, are influenced by their belief schema, i.e., all of the belief domains repre-
sented in the model. Although this resulted in our models having up to ten predictors, this
approach is in keeping with contexts in which it is appropriate to relax the rule of ten predic-
tors per number of outcomes[22];
As both the predictor and outcome variables contained missing values, imputation methods
were used to maximise the available data for the survival analysis. The independent variables
appeared to be missing completely at random: Little’s test[23] returned a p-value of 0.74. As
only 79 out of the 160 patients contained no missing values, we imputed the missing predictor
values using k-nearest neighbours, with k = 5, to ensure there was sufficient power.[24] For the
outcome measures, survival status was known for 160 patients. Of these, 24 were known to
have died, but their date of death was unknown. Thus, we performed multiple imputations to
estimate the survival time for these patients. Simulation studies[25,26] have shown that the
required number of repeated imputation methods can be as low as three for data with 20% of
missing entries. In the present work we took a conservative approach and used five imputation
techniques with 15% of missing data. The first imputation method considered the patients to
survive midway between their inclusion into the study and study end date. The second identi-
fied the average proportion of time between patients’ start dates and the study end date for all
the patients who died with a known date of death and estimated the patient’s death to be the
same ratio between their start date and the study end date. The third imputed survival time
Illness Beliefs and Mortality
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was based on the survival time of the patient with the closest start date and the fourth survival
time was based on the survival time of the four patients with the closest start date. The fifth sur-
vival time was based on the average of the previous four survival times. The Cox survival analy-
sis was performed using all five predicted survivals. Our primary analyses, therefore, focused
on the imputed dataset using the fifth survival time, as this captured all previous imputations.
However, we report results from the non-imputed dataset and the datasets using the 4 other
imputation methods in order to examine the robustness of our findings.
Missing imputation methods were implemented using R, a free software environment for
computing and graphics.[27] All other analyses used SPSS, Version 21.
Results
Cohort Characteristics
Of the 160 patients for whom data on mortality were available, n = 104 were alive at the census
point (cumulative survival rate at year 1 was 0.926); n = 32 deceased and date of death known;
and n = 24 deceased and date of death not known. No data were available from general practi-
tioners for the remaining 9 patients (no additional information given) and these patients were
excluded from the survival analyses. Analyses were conducted to compare patients with and
without survival data on all the predictor variables. No differences were evident between the
groups on any variable (data not shown), with the exception of age which approached signifi-
cance (p = 0.056): patients with missing survival data were older (mean = 65 years) compared
with patients with complete data (mean = 60 years).
Table 1 shows that the median survival period was 6.4 years; the average age of participants
was 61 years; most patients had a diagnosis of type 2 diabetes (n = 111) and, in keeping with
the known prevalence of these ulcers, two-thirds of our participants were male. The clinical
Table 1. Clinical, demographic and psychological characteristics of the cohort.
*Mean (standard deviation) / Frequency Available data (N)
Median survival (days) 2351 (+/-912) 136
Gender 120 male / 40 female 160
Age 61.21 (+/-11.85) 160
HbA1c % [mmol/mol] 8.69 (+/-1.85); [71.5] 150
Number of previous ulcers 1 (+/-2) 138
Ulcer infected at baseline 61 yes / 98 no 159
Diabetes type 1/2 Type 1 = 45/Type 2 = 111 156
Ulcer area at baseline (mm2) 17.35 (32.63) 159
Neuropathy score (%) 74 (+/-32) 152
Ischemia score (%) 70 (+/-35) 154
Depression 5.60 (+/-4.17) 128
Identity beliefs 2.90 (+/-2.82) 119
Consequence beliefs 6.42 (+/-2.16) 115
Timeline beliefs 5.98 (+/-1.84) 119
Personal control beliefs 6.16 (+/-2.42) 116
Treatment control beliefs 8.20 (+/-1.33) 117
Coherence beliefs 6.10 (+/-2.19) 119
Emotional response beliefs 5.45 (+/-2.71) 119
* Mean scores reported unless speciﬁed otherwise
doi:10.1371/journal.pone.0153315.t001
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data indicated moderately high levels of neuropathy and ischemia and average HbA1c levels
suggested poor glucose control. Most patients had had an ulcer previously and for approxi-
mately one-third of patients the index ulcer was infected at study entry. The psychological data
revealed, on average, low levels of depression. The illness beliefs measure indicated that
patients reported that they experienced few physical symptoms associated with their ulcers
(identity beliefs); believed their ulcers had significant consequences for them (consequence
beliefs); and were likely to last a moderately long time (timeline beliefs). Patients also reported
moderate levels of personal control over their ulcers (personal control beliefs), but had a greater
belief in the effectiveness of treatment (treatment control beliefs). Coherence beliefs suggested
that patients’ perceived they had a moderately good understanding of their ulcers and also
believed that their ulcers affected their emotional well-being. Pearson’s correlations between
the individual belief subscales (non-imputed data) revealed a reasonable degree of inter-corre-
lation between the subscales, with all subscales correlating with at least one other subscale. The
only exception to this was the measure of illness coherence (see Table 2).
Examining predictors of time to death
The first step in the univariate Cox regression models involved examining the role of potential
clinical and demographic predictors and depression. The results revealed that only diabetes
type (1/2) and ischemia were significant predictors of time to death (see Table 3). In the multi-
variate model, the measures of illness beliefs were added to these significant covariates. These
results showed that ischemia remained a significant predictor of time to death (HR 0.976,
p<0.0001) and that coherence (HR 0.775, p = 0.036) and identity beliefs (HR 1.245, p = 0.036)
also emerged as significant predictors, with treatment control beliefs (HR 0.735), p = 0.086)
falling below the threshold of significance. Specifically, patients with less ischemia; a poorer
understanding of their condition; who perceived they experienced more symptoms; but also a
greater belief in the effectiveness of treatment were most likely to die (see Table 3).
These analyses were repeated following imputation of missing predictor and outcome data
as described above, and the results remained largely unchanged. In particular, regardless of
which of the 5 imputation methods were used on the time to death variable, the univariate
analyses revealed that only the measures of ischemia, diabetes type (1/2) and age were signifi-
cant independent predictors of time to death (data not shown). Similarly, the multivariate anal-
yses which included the illness belief measures revealed that for all 5 imputation methods, only
ischemia and identity beliefs were significant predictors (see Table 4).
Table 2. Pearson’s product moment correlations between illness belief subscales.
Consequence
beliefs
Timeline
beliefs
Personal control
beliefs
Treatment control
beliefs
Identity
beliefs
Coherence
beliefs
Timeline beliefs 0.350 p<0.0001
Personal control beliefs -0.234 p = 0.014 -0.155
p = 0.099
Treatment control
beliefs
-0.091 p = 0.337 -0.029
p = 0.755
-0.003 p = 0.978
Identity beliefs 0.539 p<0.0001 0.394
p<0.0001
-0.305 p = 0.001 0.092 p = 0.327
Coherence beliefs 0.016 p = 0.863 0.079
p = 0.392
-0.030 p = 0.751 0.078 p = 0.406 0.071
p = 0.446
Emotional response
beliefs
0.510 p<0.0001 0.274
p = 0.003
-0.140 p = 0.134 0.211 p = 0.023 0.302
p = 0.001
-0.030 p = 0.744
doi:10.1371/journal.pone.0153315.t002
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Conclusions
We examined the role of illness beliefs in predicting time to death in patients with diabetic foot
ulcers; controlling for other potential clinical and demographic determinants. These analyses
were conducted with and without imputation of missing data. The results from the multivariate
models, without imputation, revealed that ischemia, coherence and identity beliefs predicted
time to death. Specifically, death occurred more quickly in individuals with less ischemia, who
Table 3. Cox regression analyses examining predictors of time to death.
Univariate analyses 1Multivariate analysis
Covariate Hazard ratios p 95%CI Covariate Hazard ratios p 95%CI
Age 1.021 .179 .990–1.053 Diabetes 1/2 .395 .107 .128–1.223
Gender 1.029 .945 .462–2.291 Ischemia score .976 .000 .965-.987
Ulcer area at baseline (mm2) 1.003 .585 .993–1.012 Consequence beliefs .959 .817 .671–1.370
Ulcer infected at baseline .792 .512 .394–1.592 Timeline beliefs .993 .965 .717–1.374
Diabetes 1/2 .304 .026 .107-.868 Personal control beliefs 1.085 .465 .872–1.351
Number of previous ulcers 1.086 .182 .962–1.227 Treatment control beliefs .735 .086 .517–1.045
HbA1c .869 .181 .708–1.067 Identity beliefs 1.245 .036 1.014–1.529
Depression .975 .579 .892–1.066 Coherence beliefs .775 .036 .610-.983
Neuropathy 1.005 .381 .994–1.017 Emotional response beliefs .890 .274 .722–1.097
Ischemia score .975 < .0001 .966-.985
1 Multivariate analysis included only signiﬁcant covariates identiﬁed in univariate analyses and all illness beliefs
doi:10.1371/journal.pone.0153315.t003
Table 4. Cox regression analyses using imputed data to examine effects of significant clinical and demographic covariates and illness beliefs on
time to death.
Imput-
ation 1
Imput-
ation 2
Imput-
ation 3
Imput-
ation 4
Imput-
ation 5
Covariate HR p 95%CI HR p 95%CI HR p 95%CI HR p 95%CI HR p 95%CI
Age 1.283 .094 .958–
1.717
1.315 .065 .983–
1.760
1.257 .126 .938–
1.684
1.252 .130 .936–
1.676
1.272 .108 .949–
1.705
Diabetes 1/2 0.602 192 .281–
1.291
0.591 .175 .277–
1.263
0.613 .211 .2858–
1.320
0.583 .173 .269–
1.266
0.607 .203 .282–
1.309
Ischemia .425 .000 .313-
.578
.420 .000 .308-
.573
.418 .000 .308-
.566
.405 .000 .298-
.551
.415 .000 .305-
.564
Consequence
beliefs
.732 .176 .465–
1.151
.706 .133 .448–
1.112
.848 .466 .545–
1.32
.828 .407 .530–
1.293
.807 .342 .518–
1.257
Timeline beliefs 1.280 .236 .851–
1.925
1.250 .279 .834–
1.873
1.189 .381 .808–
1.75
1.157 .460 .786–
1.702
1.24 .286 .835–
1.841
Personal
control beliefs
1.277 .261 .834–
1.954
1.276 .264 .833–
1.954
1.206 .367 .803–
1.812
1.182 .415 .791–
1.766
1.228 .333 .810–
1.860
Treatment
control beliefs
.770 .145 .542–
1.094
.746 .101 .526–
1.059
.790 .186 .557–
1.121
.799 .209 .563–
1.134
.783 .173 .550–
1.113
Identity beliefs 1.809 .017 1.113–
2.940
1.995 .007 1.213–
3.281
1.622 .050 1.001–
2.628
1.654 .040 1.022–
2.675
1.669 .038 1.028–
2.71
Coherence
beliefs
.796 .227 .550–
1.152
.769 .161 .532–
1.111
.828 .317 .573–
1.198
.796 .220 .552–
1.146
.808 .260 .557–
1.172
Emotional
response
beliefs
.729 .120 .489–
1.086
.733 .129 .491–
1.095
.756 .156 .514–
1.113
.737 .128 .497–
1.092
.741 .134 .500–
1.097
doi:10.1371/journal.pone.0153315.t004
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perceived their ulcers were associated with greater symptoms and had a poorer understanding
of their condition. When these analyses were repeated with imputation of missing data for
both predictor and outcome variables, the findings were largely unchanged, with degree of
ischemia and identity beliefs emerging as significant predictors of both mortality and time to
death in all analyses. In view of the increased power associated with the imputed datasets, the
discussion of our findings will focus, primarily, on these results.
Our findings have several implications. First, they add to an existing literature which has
shown that patients’ illness beliefs can influence clinical outcomes in diabetes (e.g., quality of
life, glycaemic control[11,12]): with the present work identifying an independent role for illness
beliefs in predicting survival. These results are also in keeping with findings from other patient
groups[15,16] and a recent systematic review[28] all of which have shown how beliefs regard-
ing one’s illness are predictive of mortality over periods as short as 1.32 years[15] and as long
as 10 years.[16]
Second, these results suggest that approaches to understanding mortality risk in this patient
group[29] may be improved through the inclusion of illness beliefs in risk models. Our data
showed that, even after controlling for other predictors, illness beliefs predicted survival; and
that identity beliefs emerged as being of particular importance. Indeed, evidence suggesting
that illness beliefs are not only modifiable, but that illness belief based interventions can pro-
duce significant changes in a range of outcomes (e.g., adherence behaviours, mood, return to
work) and across many different diseases, including diabetes [30–33]; suggests that the mea-
surement of illness beliefs may not only improve our understanding of the risk factors associ-
ated with mortality, but could also be incorporated into interventions to improve survival.
Although detailed consideration of the features and mechanisms of such an intervention is
beyond the scope of this paper, it could be hypothesised that evidence identifying significant
relationships between illness beliefs and glycaemic control[11] and illness beliefs and self-care
behaviours[13] suggests that any such intervention could improve survival via these pathways.
The third issue concerns the seemingly central role of identity beliefs in predicting mortal-
ity. Identity beliefs are concerned with an individual’s perception of the extent to which their
condition is symptomatic and are often associated with more favourable outcomes (e.g., better
adherence, attendance at cardiac rehabilitation, etc.[34,35] In contrast, in the present study the
experience of greater foot ulcer symptoms was associated with a faster, not slower, time to
death. This finding could simply reflect the fact patients with greater symptoms had more
severe disease which resulted in the greater risk of mortality. This explanation, however, is not
consistent with what is known about neuropathic and neuroischemic foot ulcers. Nerve dam-
age is a defining feature of such ulcers. Consequently, the more severe the underlying pathol-
ogy, the more likely the patient will experience fewer symptoms. Thus, if we were considering a
pathophysiological explanation alone, then the experience of fewer symptoms (an indication of
more severe disease) might be associated with a faster time to death, rather than the converse.
Our data clearly do not allow us to delineate precisely why patients who believe their ulcers
are associated with greater symptoms might experience a faster time to death. But it may be
possible to speculate to possible pathways based on the relationship between identity beliefs
and the other belief domains. In particular, significant positive associations were evident
between identity beliefs and consequence, timeline and emotional response beliefs; as well as a
significant negative correlation with personal control beliefs. Thus, patients who perceived
their ulcers were associated with greater symptoms also believed that their ulcers had more
serious consequences for them, would last a long time, that they were associated with greater
emotional distress and less personal control. This constellation of beliefs may have led to
unhelpful behavioural and/or emotional responses (e.g., poorer adherence to treatment) lead-
ing to the observed association with mortality.
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We acknowledge that our understanding of the relationship between identity beliefs and
mortality is significantly compromised by the fact that our understanding of patients’ beliefs
was limited to responses to a single item which does not give us insight into the types of symp-
toms that patients were considering when responding. Future work, using either qualitative
methods,[36] and/or which capture illness beliefs using more detailed methods such as the Ill-
ness Perceptions Questionnaire—Revised[37] could help to illuminate this relationship
between identity beliefs and mortality.
A further related issue concerns the fact that previous work looking at the relationship
between illness beliefs and mortality has identified a role for treatment control beliefs, not iden-
tity beliefs, in predicting mortality.[14,15] This may be due to differences in the disease charac-
teristics of the patient groups: both of the cited studies focused on patients with renal disease.
However, it is also possible the divergent findings relate to differences in the statistical
approaches taken. Both studies examined the effects of each illness belief dimension individu-
ally in univariate analysis and then, added the significant belief(s) (which in both studies was
treatment control) to an adjusted model which included the significant clinical and demo-
graphic covariates. This alternative approach, although wholly appropriate, does not permit
consideration of the effects of the entire belief schema; and it is possible that the effects of iden-
tity beliefs are only evident when the schema is considered.
A fourth issue relates to our finding that ischemia was associated with a survival advantage.
As with identity beliefs, ischemia was found to predict time to death in all analyses, thereby
suggesting that, although counterintuitive, it was a robust finding. However, a number of issues
should be considered when interpreting this result. First, our approach to measuring ischemia
involved a single assessment (i.e., the measurement of the number of palpable pulses). How-
ever, the accurate measurement of ischemia requires multiple, not single, methods.[38] Thus,
our approach, while pragmatic (we selected one method which could be conducted rapidly
across all clinics), lacked precision and this may have contributed to our finding. Second, as
stated, our inclusion criteria were intended to enable us to recruit patients with neuropathic or
neuroischaemic ulcers i.e., patients with no palpable pulses (severe ischemia) were excluded.
As a result, the patients in this cohort with the greatest levels of ischemia, were likely to be indi-
viduals with only moderate ischemic disease; and patients with low levels of ischemia likely to
be patients experiencing greater neuropathy. As the treatments for microvascular complica-
tions such as neuropathy are considered not to be as effective as treatments for macrovascular
complications,[39] this might explain the apparent survival advantage in our patients with
moderate ischemia. In other words, moderate ischemia in this study may have been a marker
of less severe neuropathy thus contributing to the observed relationship with mortality and
time to death.
The final issue relates to the observation that depression did not influence survival. This
finding is consistent with research showing that the effects of depression on clinical outcomes
in diabetes are equivocal.[29] Indeed, our data support a growing literature suggesting that a
focus on depression in isolation may not be helpful when considering how psychological fac-
tors, and psychological interventions, influence clinical outcomes in diabetes.[12,40,41] In the
case of the present work, we were unable to detect a statistically significant independent effect
of depression. However, it is worth noting that post-hoc analyses (data not shown) revealed
that depression was significantly positively correlated with identity beliefs, thus suggesting the
potential for an indirect effect of depression on mortality outcomes.
In summary, our analyses have shown a significant independent effect of patients’ illness
beliefs on survival in patients with diabetic foot ulcers. Potential limitations of this work relate
to the observational design, the modest sample size, the exclusion of patients for whom we
were unable to obtain survival data from clinical records and the limited number of events
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(deaths) in our cohort. The latter issue was, of course, a function of our data. We did, however,
endeavour to make sure we were able to use as much data as possible through the use of multi-
ple imputation methods. Similarly, with regard to our sample size, it is worth noting that,
although modest, it was greater than the mean sample size reported in a systematic review of
previous work examining the role of illness beliefs in survival[28]; and our excluded patients
did not differ from the rest of the cohort on any of the predictors of survival.
A further consideration is that our analyses focussed on patients with predominantly neuro-
pathic or neuroischaemic ulcers and poor glucose control. Although this is common in patients
with diabetic foot disease, it does potentially limit the generalisability of our findings beyond
this patient group. Finally, our approach to measuring illness beliefs was pragmatic but lacked
precision. Although the brief IPQ is particularly suitable for studies with older and/or frail
patients, it relies on single items for the measurement of each belief domain and this necessarily
precludes a detailed analysis of patients’ beliefs. Notwithstanding these limitations, these results
broaden our understanding of the role of psychological processes in diabetes and add to the
growing literature suggesting that individuals’ beliefs about their illness may have prognostic
significance.
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